ALLMedicine™ Type 2 Diabetes Center

Apr 21st, 2021 - Type 2 diabetes (T2DM) and COPD are chronic medical conditions, for which patients need lifelong healthcare. The aim of this study is to examine in which healthcare setting patients with T2DM and COPD receive their care, and if this is the correct...

Apr 21st, 2021 - Non-alcoholic fatty liver disease (NAFLD) affects 20-30% of the general adult population. NAFLD patients with type 2 diabetes mellitus (T2DM) are at an increased risk of advanced fibrosis, which puts them at risk of cardiovascular complications, h...

Apr 21st, 2021 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes as they stimulate insulin release and promote weight loss through appetite suppression. Their main side effect is nausea. All approved GLP-1RAs are f...

Apr 21st, 2021 - Post-transplant diabetes mellitus (PTDM) is a common complication of solid organ transplantation and a major cause of increased morbidity and mortality. Additionally, solid organ transplant patients may have pre-existent type 2 diabetes mellitus (...

Apr 21st, 2021 - Tens of millions of individuals in the United States have Type 2 diabetes, and most require treatment with glucose-lowering medications to manage the disease. To examine trends in non-insulin drug treatment of Type 2 diabetes, including first-line...

Mar 15th, 2021 - According to the Centers for Disease Control and Prevention’s (CDC’s) 2020 National Diabetes Statistics Report, an estimated 13% of all U.S. adults (age ≥18 years) have diabetes, and 34.5% meet criteria for prediabetes.1 The prevalence of prediabe...

Mar 8th, 2021 - Studies show that certain common medical conditions put people at higher risk for severe illness from COVID-19. These include metabolic disorders like type 2 diabetes and obesity, as well as heart conditions like high blood pressure (hypertension)...

Feb 3rd, 2021 - The majority of adults in the U.S. carry too much fat in their bodies and are now considered overweight or obese. The last several decades have also seen a spike in related diseases of metabolism, such as type 2 diabetes.

Feb 1st, 2021 - Too much white fat, a characteristic of obesity, has been shown to increase the risk of type 2 diabetes, high blood pressure, and other diseases. A less common type of fat, called brown fat, uses blood sugar and fat molecules to create heat and he...

Jan 5th, 2021 - COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 di...

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

Apr 21st, 2021 - Type 2 diabetes (T2DM) and COPD are chronic medical conditions, for which patients need lifelong healthcare. The aim of this study is to examine in which healthcare setting patients with T2DM and COPD receive their care, and if this is the correct...

Apr 21st, 2021 - Non-alcoholic fatty liver disease (NAFLD) affects 20-30% of the general adult population. NAFLD patients with type 2 diabetes mellitus (T2DM) are at an increased risk of advanced fibrosis, which puts them at risk of cardiovascular complications, h...

Apr 21st, 2021 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes as they stimulate insulin release and promote weight loss through appetite suppression. Their main side effect is nausea. All approved GLP-1RAs are f...

Apr 21st, 2021 - Post-transplant diabetes mellitus (PTDM) is a common complication of solid organ transplantation and a major cause of increased morbidity and mortality. Additionally, solid organ transplant patients may have pre-existent type 2 diabetes mellitus (...

Apr 20th, 2021 - Calorie-restricted diets followed by gradual food reintroduction may not only lead to remission of type 2 diabetes but also normalise cardiovascular disease risk and heart age, the results of a UK analysis suggest. Moreover, the approach is transf...

Apr 5th, 2021 - Cardiovascular disease was the leading cause of death among the over 16,000 patients with type 2 diabetes (T2DM) who were enrolled in the SAVOR-TIMI 53 trial. Two-thirds (66.3%) of all 798 deaths after a median 2.1 years of follow-up were caused b...

Apr 5th, 2021 - As a result of the COVID-19 pandemic, the United States will likely face a tsunami of death and disability from common chronic diseases that will affect society for decades, Robert Califf, MD, former commissioner of the US Food and Drug Administra...

Apr 1st, 2021 - NEW YORK (Reuters Health) - Lowering elevated lipoprotein(a) levels with the PCSK9 inhibitor alirocumab may be associated with a slightly increased risk of developing type-2 diabetes, but the benefit appears to outweigh the potential risk, new res...

Apr 1st, 2021 - Takeaway Type 2 diabetes (T2D) patients prescribed metformin, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and sulfonylureas were at a lower risk of COVID-19-related mortality than those not prescribed these drugs.